middle.news
How Rhythm Biosciences Is Poised to Transform Colorectal Cancer Detection in 2026
9:11am on Wednesday 29th of October, 2025 AEDT
•
Healthcare
Read Story
How Rhythm Biosciences Is Poised to Transform Colorectal Cancer Detection in 2026
9:11am on Wednesday 29th of October, 2025 AEDT
Key Points
Successful $3.75 million capital raise oversubscribed
ColoSTAT® achieves final clinical validation and manufacturing readiness
Genetype platform revenue grows over 100% quarter-on-quarter
Strategic partnerships secured with Memorial Sloan Kettering and Know Your Lemons Foundation
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Rhythm Biosciences (ASX:RHY)
OPEN ARTICLE